Skip to main content
Clinical Trials/NCT01182402
NCT01182402
Completed
Not Applicable

Electronic Compliance Monitoring in Opioid Substitution Treatment

Kuopio University Hospital1 site in 1 country37 target enrollmentSeptember 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Opiate Dependence
Sponsor
Kuopio University Hospital
Enrollment
37
Locations
1
Primary Endpoint
The effectiveness of treatment (Treatment Outcomes Profile TOP)
Status
Completed
Last Updated
15 years ago

Overview

Brief Summary

The purpose of this study is to improve unsupervised dosing of opioid substitution medications. The aim of the study is to examine whether electronic compliance monitoring provides some advantages to patients'treatment and what kind of patients especially benefit from monitoring. We would also like to know if electronic compliance monitoring can prevent the abuse/diversion of medications and how implementing this method to wider treatment facilities succeeds.

Registry
clinicaltrials.gov
Start Date
September 2010
End Date
February 2011
Last Updated
15 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Kuopio University Hospital

Eligibility Criteria

Inclusion Criteria

  • opiate dependence F11.22 according to ICD-10
  • Suboxone treatment
  • the duration of substitution treatment before study at least one month
  • stable medication dose

Exclusion Criteria

  • unstable situation in life according to treatment staff's opinions

Outcomes

Primary Outcomes

The effectiveness of treatment (Treatment Outcomes Profile TOP)

Time Frame: Every two months.

Structured interview designed to measure the effectiveness and outcomes of opioid substitution treatment.

Secondary Outcomes

  • Patients´opinions about the treatment.(Once when the study phase ends (after four months).)

Study Sites (1)

Loading locations...

Similar Trials